Exo Biologics
Company
Liège, BelgiumAbout
Exo Biologics is a clinical-stage biotechnology company developing extracellular vesicle (EV)-based therapeutics for inflammatory, neurological, and regenerative diseases. Its lead candidate, EXOB-001, is currently in Phase I/II clinical development.
As part of Shuttle to Brain, an Interreg project, Exo Biologics uses radioligands to investigate the biodistribution of its EVs. The project also aims to explore the potential of EVs as delivery vehicles for therapeutic payloads to the brain.
Areas of activity
Application Domain
BiopharmaAdvanced Therapies
Technology
Biologics
Therapeutic Area
ImmunologyNeurologyPediatricsPneumologyRare Diseases
Representatives
CBO
Exo Biologics